Home / Stocks / PMCUF

Pro Medicus Limited (PMCUF, Healthcare software) Stock Valuation & Fair Value

Poor on forward returns

Pro Medicus Limited (PMCUF, Healthcare software) trades at a current P/E of 132.7, about 15% above its historical normal valuation, with a forward growth estimate of 27.9% and a PEG of 4.76. Analysts' one-year estimates have been hit 55% of the time. Priced at its historical normal P/E of 115.5 on the same blended earnings, the 2026-11-06 close of $140.74 corresponds to about $122 a share. This is a valuation reference, not a price target. The $140.74 close is the one the P/E is read at; the technical context below uses the 2026-11-05 close, $144.00.

How to read these numbers: the PEG ratio and current P/E versus normal P/E.

DATA AS OF 2026-11-07
Current P/E
132.7
Normal P/E
115.5
PEG
4.76
Fwd growth
27.9%
Div yield
0.3%
RSI (14)
77.8
Overbought
Technical context
  • Price $144.00 at the Nov 5 close, 14.5% above the 20-day average ($125.78) and 19.8% above the 50-day ($120.25).
  • RSI (14) at 77.8.
  • 52-week range $76.09 to $178.70: the price is 19.4% below the high and 89.2% above the low.

Valuation flags

Verdict history

tickerseer's rating has been poor on forward returns since 2026-09-19.

Current P/E and rating by weekCurrent P/E moved from 121.4 to 128.8 between 2026-09-18 and 2026-10-30, against a normal P/E of 111.2, with 0 rating changes over 7 recorded weeks.2026-09-18: P/E 121.4, Poor on forward returns, recalculated for the week of 2026-09-192026-09-18: P/E 121.4, Poor on forward returns, recorded live 2026-09-212026-09-25: P/E 113.8, Poor on forward returns, recalculated for the week of 2026-09-262026-09-25: P/E 113.8, Poor on forward returns, recorded live 2026-09-282026-10-02: P/E 108.8, Poor on forward returns, recalculated for the week of 2026-10-032026-10-02: P/E 108.8, Poor on forward returns, recorded live 2026-10-052026-10-09: P/E 114.4, Poor on forward returns, recalculated for the week of 2026-10-102026-10-09: P/E 114.4, Poor on forward returns, recorded live 2026-10-122026-10-16: P/E 120.5, Poor on forward returns, recalculated for the week of 2026-10-172026-10-16: P/E 120.5, Poor on forward returns, recorded live 2026-10-192026-10-23: P/E 126.6, Poor on forward returns, recalculated for the week of 2026-10-242026-10-23: P/E 126.6, Poor on forward returns, recorded live 2026-10-262026-10-30: P/E 128.8, Poor on forward returns, recalculated for the week of 2026-10-312026-10-30: P/E 128.8, Poor on forward returns, recorded live 2026-11-02110.0115.0120.0125.0Sep 18Sep 28Oct 9Oct 20Oct 30Normal P/E 111.2
Poor on forward returns

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, and the cheapest and dearest.

WeekCurrent P/EPremium to normal P/ERating
2026-09-19P/E 121.4+9%Poor on forward returns (recalculated)
2026-10-03P/E 108.8-2%Poor on forward returns (recalculated)
2026-10-31P/E 128.8+16%Poor on forward returns (recalculated)
2026-11-02P/E 128.8+16%Poor on forward returns ← now
Show all 14 readings
WeekCurrent P/EPremium to normal P/ERating
2026-09-19P/E 121.4+9%Poor on forward returns (recalculated)
2026-09-21P/E 121.4+9%Poor on forward returns
2026-09-26P/E 113.8+2%Poor on forward returns (recalculated)
2026-09-28P/E 113.8+2%Poor on forward returns
2026-10-03P/E 108.8-2%Poor on forward returns (recalculated)
2026-10-05P/E 108.8-2%Poor on forward returns
2026-10-10P/E 114.4+3%Poor on forward returns (recalculated)
2026-10-12P/E 114.4+3%Poor on forward returns
2026-10-17P/E 120.5+8%Poor on forward returns (recalculated)
2026-10-19P/E 120.5+8%Poor on forward returns
2026-10-24P/E 126.6+14%Poor on forward returns (recalculated)
2026-10-26P/E 126.6+14%Poor on forward returns
2026-10-31P/E 128.8+16%Poor on forward returns (recalculated)
2026-11-02P/E 128.8+16%Poor on forward returns ← now

Frequently asked questions

Is Pro Medicus Limited stock overvalued?

At a current P/E of 132.7 versus its historical normal P/E of 115.5, Pro Medicus Limited trades about 15% above its typical valuation, with a PEG of 4.76 on 27.9% forward growth. tickerseer currently rates it poor on forward returns.

What is Pro Medicus Limited's fair value and PEG?

Pro Medicus Limited trades at a current P/E of 132.7 against a historical normal P/E of 115.5, a PEG of 4.76, and a forward growth estimate of 27.9%. Priced at its historical normal P/E of 115.5 on the same blended earnings, the 2026-11-06 close of $140.74 corresponds to about $122 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Pro Medicus Limited changed?

tickerseer's rating has been poor on forward returns since 2026-09-19.

Industry: Healthcare software. Create a free account to see the full analysis: the SeerAI score, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track PMCUF free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.